间充质干细胞
材料科学
脐带
球体
干细胞
体内
再生医学
血管生成
细胞生物学
癌症研究
生物
免疫学
细胞培养
生物技术
遗传学
作者
Yong Qiao,Zhongjuan Xu,Yanzhen Yu,Shulan Hou,Junsa Geng,Tongqian Xiao,Yu Liang,Qun Dong,Mei Yan,Bin Wang,Hong Qiao,Jianwu Dai,Guangli Suo
出处
期刊:Biomaterials
[Elsevier]
日期:2020-01-01
卷期号:227: 119573-119573
被引量:40
标识
DOI:10.1016/j.biomaterials.2019.119573
摘要
Umbilical cord mesenchymal stem cells (UCMSCs) have shown great potentials in regenerative medicine for their extensive sources, multilineage differentiation potential, low immunogenicity and self-renewal ability. However, the clinical application of UCMSCs still confronts many challenges including the requirement of large quantity of cells, low survival ability in vivo and the loss of main original characteristics due to two-dimensional (2D) culture. The traditional three-dimensional (3D)-spheroid culture can mimic in vivo conditions, but still has limitations in clinical application due to large size of spheroid against direct injection and inner cell death. Based on self-renewal tenet, we produced single cell derived sphere (SCDS) of UCMSCs through combining single cell pattern on chip with 3D culture. Compared with the 2D and traditional 3D culture, SCDS culture has many advantages to meet clinical requirements, including small size, higher abilities of survival and migration, and stronger hypoxia resistance and stemness maintenance. Furthermore, SCDS culture promotes angiogenesis in UCMSCs-xenografts and displays greater therapeutic potential on acute liver failure (ALF) in vivo. Our results suggest that SCDS culture may serve as a simple and effective strategy for UCMSCs optimization to meet clinical demand.
科研通智能强力驱动
Strongly Powered by AbleSci AI